Key facts
- It has raised $530K; the latest was Angel (individual) ($530K) in Mar 2025.
- Notable investors include National Institutes of Health, University of Virginia, KY SBIR Matching Fund, Launch Blue, National Cancer Institute — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Carina Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Carina Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Carina Medical
Developer of an artificial intelligence (AI)-based medical image analysis software designed for radiation oncology and radiology applications. The company's software provides novel technologies for efficient radiation treatment, which will assist in both computed tomography and magnetic resonance imaging-based organ segmentation and site-specific segmentation models to enhance the robustness of the AI system, enabling doctors with an efficient workflow for radiation therapy and improving cancer treatment.
- Sector
- Healthcare
- HQ
- Lexington, KY, United States
- Founded
- 2018
- Employees
- 5
- Website
- carinaai.com/
- Ownership
- Privately Held (backing)
Carina Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Carina Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Carina Medical in its N-PORT filings yet. We sweep new filings monthly.